Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4.

The American journal of gastroenterology - 1 Sept 2004

Hasan Fuad, Asker Haifa, Al-Khaldi Jameela, Siddique Iqbal, Al-Ajmi Misfer, Owaid Salim, Varghese Rosh, Al-Nakib Basil

Abstract excerpt

BACKGROUND: The hepatitis C virus (HCV) genotype is an important predictive parameter for the success of pegylated interferon plus ribavirin therapy. To date, most published therapeutic trials have enrolled patients infected mainly with HCV genotypes 1, 2, and 3. Data regarding the responsiveness of genotype 4, the predominant type of HCV in the Middle East, are very limited. OBJECTIVE: To assess the efficacy of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Liver Function Tests

Share to Polyethylene Glycols

Share to Probability

Share to Ribavirin

Share to Sampling Studies

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 15330911
DOI: 10.1111/j.1572-0241.2004.40077.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4.PMID 15330911Read ↗

Hepatitis C genotype 4Semantic proximity Read ↗

Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin.Semantic proximity Read ↗

Hepatitis C virus genotype 4 therapy: progress and challenges.Semantic proximity Read ↗

Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT.Semantic proximity Read ↗

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4.Semantic proximity Read ↗

Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4.Semantic proximity Read ↗

Hepatitis C genotype 4 therapy: increasing options and improving outcomes.Semantic proximity Read ↗

Management of hepatitis C virus genotype 4: recommendations of an international expert panel.Semantic proximity Read ↗

Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.Semantic proximity Read ↗

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.Semantic proximity Read ↗

Determinants of Infection Outcome in HCV-Genotype 4.Semantic proximity Read ↗

Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.